Lynne Powell - 14 Jun 2023 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role: Director
Signature: /s/ Clarke Neumann, Attorney-in-Fact for Lynne Powell
Issuer symbol: BIORQ
Transactions as of: 14 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 16 Jun 2023, 16:06:07 UTC
Previous filing: 05 Jan 2023
Next filing: 06 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIOR	Common Stock	Award	$0	+12,500	+218%	$0.000000	18,246	14 Jun 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIOR	Stock Option (Right to Buy)	Award	$0	+12,500		$0.000000	12,500	14 Jun 2023	Common Stock	12,500	$4.70	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 12,500 restricted stock units, which vest in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
F2	This option represents the right to purchase 12,500 shares of the Issuer's common stock, and vests in full on the earlier of (1) the first anniversary of the grant date or (2) the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.